Title | Allergic Asthma and CIU Treatment | XOLAIR® (Omalizumab) |
Description | XOLAIR (omalizumab) for subcutaneous use is a prescription treatment for moderate to severe persistent allergic asthma not controlled with ICS and chronic idiopathic urticaria (CIU) in appropriate patients. See full safety & Boxed Warning |
Keywords | xolair, xolair injection, omalizumab, allergic asthma, allergic asthma treatment, allergy symptoms, year-round allergens, patient support program, severe asthma, ciu, chronic idiopathic urticaria, chronic hives |
xolairhcp.com |
ciuandyou.com |
xolaircopay.com |
genentech-access.com |
nucala.com |
candypasses.com |
uccu.com |
yugioh-card.com |
brownwoodpd.org |
pracawroclaw.org |
yugioh-forum.com |
rentemeraldisland.com |
nccosmeticarts.com |
thepharmaletter.com |
burghfieldhouse.co.uk |
Xolair.com was created 25 years ago. According to Alexa, it has a global traffic rank of #1,983,178 globally. Xolair.com receives approximately 8,874 unique visitors per month. Web server is located in United States and has an IP address 52.52.174.250.
Creation date | 1999-12-08 |
Expiration date | 2021-12-07 |
Registrar | MarkMonitor, Inc. |
Name servers |
|
IP address | 52.52.174.250 |
Server located | United States, San Jose |
Host name | ec2-52-52-174-250.us-west-1.compute.amazonaws.com |
Global Rank | 1,983,178 |
Delta (90 Days) | 593,246 |
Most Popular In Country | n/a |
Country Rank | n/a |
Host | Type | TTL | Data |
---|---|---|---|
xolair.com | A | 7198 |
ip: 52.52.174.250 |
xolair.com | NS | 86400 |
target: dns2.novartis.com |
xolair.com | NS | 86400 |
target: dns3.novartis.com |
xolair.com | NS | 86400 |
target: dns1.novartis.com |
xolair.com | NS | 86400 |
target: dns4.novartis.com |
xolair.com | SOA | 86400 |
mname: dns1.novartis.com rname: hostmaster.novartis.com serial: 2020101202 refresh: 28800 retry: 7200 expire: 604800 minimum-ttl: 3600 |
xolair.com | TXT | 86400 |
txt: 1b2acf09-187d-4b9c-8368-2b7cd922639d |
xolair.com | TXT | 86400 |
txt: q54p5sc96j0zz1qmt5l71gqzh89wm10w |
Accept-Ranges: bytes Content-Type: text/html; charset=UTF-8 Date: Tue, 17 Nov 2020 15:34:03 GMT Server: Apache Vary: Accept-Encoding Connection: keep-alive x-encoded-content-encoding: gzip x-encoded-content-length: 14539 |
Domain Name: xolair.com Registry Domain ID: 14823155_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.markmonitor.com Registrar URL: http://www.markmonitor.com Updated Date: 2020-11-17T00:10:02-0800 Creation Date: 1999-12-08T00:00:00-0800 Registrar Registration Expiration Date: 2021-12-07T00:00:00-0800 Registrar: MarkMonitor, Inc. Registrar IANA ID: 292 Registrar Abuse Contact Email: abusecomplaints@markmonitor.com Registrar Abuse Contact Phone: +1.2083895770 Domain Status: clientUpdateProhibited (https://www.icann.org/epp#clientUpdateProhibited) Domain Status: clientTransferProhibited (https://www.icann.org/epp#clientTransferProhibited) Domain Status: clientDeleteProhibited (https://www.icann.org/epp#clientDeleteProhibited) Registry Registrant ID: Registrant Name: Domain Admin Registrant Organization: Novartis AG Registrant Street: P.O. Box CH-4002, Registrant City: Basel Registrant State/Province: CH Registrant Postal Code: 4002 Registrant Country: CH Registrant Phone: +1.2083895740 Registrant Phone Ext: Registrant Fax: +1.2083895799 Registrant Fax Ext: Registrant Email: novartis.domains@markmonitor.com Admin Organization: MarkMonitor, Inc. Admin State/Province: ID Admin Country: US Admin Email: Select Request Email Form at https://domains.markmonitor.com/whois/xolair.com Tech Organization: MarkMonitor, Inc. Tech State/Province: ID Tech Country: US Tech Email: Select Request Email Form at https://domains.markmonitor.com/whois/xolair.com Name Server: dns2.novartis.com Name Server: dns4.novartis.com Name Server: dns1.novartis.com Name Server: dns3.novartis.com DNSSEC: unsigned URL of the ICANN WHOIS Data Problem Reporting System: http://wdprs.internic.net/ |